Cargando…

Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study

INTRODUCTION: Early diagnosis of intensive care unit – acquired weakness (ICU-AW) using the current reference standard, that is, assessment of muscle strength, is often hampered due to impaired consciousness. Biological markers could solve this problem but have been scarcely investigated. We hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieske, Luuk, Witteveen, Esther, Petzold, Axel, Verhamme, Camiel, Schultz, Marcus J, van Schaik, Ivo N, Horn, Janneke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057240/ https://www.ncbi.nlm.nih.gov/pubmed/24443841 http://dx.doi.org/10.1186/cc13699

Ejemplares similares

Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study
por: Wieske, Luuk, et al.
Publicado: (2015)

Causes of Mortality in ICU-Acquired Weakness
por: van Wagenberg, Linda, et al.
Publicado: (2017)

Assessment of intensive care unit‐acquired weakness in young and old mice: An E. coli septic peritonitis model
por: Witteveen, Esther, et al.
Publicado: (2015)

Early Prediction of Intensive Care Unit–Acquired Weakness Using Easily Available Parameters: A Prospective Observational Study
por: Wieske, Luuk, et al.
Publicado: (2014)

Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study
por: Witteveen, Esther, et al.
Publicado: (2017)

Early electrophysiological diagnosis of ICU-acquired weakness
por: Wieske, L, et al.
Publicado: (2014)

Increased early systemic inflammation in patients with ICU-acquired weakness
por: Witteveen, E, et al.
Publicado: (2015)

Early Prediction of Intensive Care Unit–Acquired Weakness: A Multicenter External Validation Study
por: Witteveen, Esther, et al.
Publicado: (2018)

Examination of the autonomic nervous system in the ICU: a pilot study
por: Wieske, L, et al.
Publicado: (2012)

ICU-acquired weakness
por: Vanhorebeek, Ilse, et al.
Publicado: (2020)

The role of inflammation in ICU-acquired weakness
por: Winkelman, Chris
Publicado: (2010)

The 2022 Lady Estelle Wolfson lectureship on neurofilaments
por: Petzold, Axel
Publicado: (2022)

Epidemiology, management and clinical outcomes of ICU-acquired enterococcal bacteraemias
por: Ong, DSY, et al.
Publicado: (2014)

Cisatracurium-besilate: ICU-acquired weakness: case report
Publicado: (2022)

0520. The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness
por: Jiroutkova, K, et al.
Publicado: (2014)

Withholding parenteral nutrition for 1 week reduces ICU-acquired weakness
por: Hermans, G, et al.
Publicado: (2013)

ICU-acquired weakness: should medical sovereignty belong to any specialist?
por: Intiso, Domenico
Publicado: (2018)

The role of the microcirculation and integrative cardiovascular physiology in the pathogenesis of ICU-acquired weakness
por: Mendelson, Asher A., et al.
Publicado: (2023)

The Diagnostic and Prognostic Value of Neurofilament Heavy Chain Levels in Immune-Mediated Optic Neuropathies
por: Petzold, Axel, et al.
Publicado: (2012)

Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness
por: Tzanis, Georgios, et al.
Publicado: (2011)

ICU-acquired weakness: what is preventing its rehabilitation in critically ill patients?
por: Lee, Christie M, et al.
Publicado: (2012)

Effect of early activity combined with early nutrition on acquired weakness in ICU patients
por: Zhou, Wendie, et al.
Publicado: (2020)

Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study
por: Adrichem, M. E., et al.
Publicado: (2019)

Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest
por: Rundgren, Malin, et al.
Publicado: (2012)

Diaphragm Dysfunction and ICU-Acquired Weakness in Septic Shock Patients with or without Mechanical Ventilation: A Pilot Prospective Observational Study
por: Takahashi, Yuta, et al.
Publicado: (2023)

Winning the war against ICU-acquired weakness: new innovations in nutrition and exercise physiology
por: Wischmeyer, Paul E, et al.
Publicado: (2015)

A promising new therapy may assist efforts to combat ICU-acquired weakness
por: Bain, Sarah, et al.
Publicado: (2014)

Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness
por: Jiroutková, Kateřina, et al.
Publicado: (2015)

Intervention effect of neuromuscular electrical stimulation on ICU acquired weakness: A meta-analysis
por: Liu, Miao, et al.
Publicado: (2020)

Role of ICU-acquired weakness on extubation outcome among patients at high risk of reintubation
por: Thille, Arnaud W., et al.
Publicado: (2020)

ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patients
por: Saccheri, Clément, et al.
Publicado: (2020)

Influence of Early Multidisciplinary Collaboration on Prevention of ICU-Acquired Weakness in Critically Ill Patients
por: Wang, Bolan, et al.
Publicado: (2022)

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial
por: Verhamme, Camiel, et al.
Publicado: (2009)

Seven day pre-analytical stability of serum and plasma neurofilament light chain
por: Altmann, Patrick, et al.
Publicado: (2021)

Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study
por: Lim, Johan, et al.
Publicado: (2020)

Recovery of muscle weakness and physical function in a patient with severe ICU‐acquired weakness following pulmonary embolism: A case report
por: Morimoto, Yosuke, et al.
Publicado: (2018)

The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy – A prospective, pilot observational study
por: Ehler, Johannes, et al.
Publicado: (2019)

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial
por: van Veen, Robin, et al.
Publicado: (2022)

Neurofilament light chain levels predict encephalopathy and outcome in community‐acquired pneumonia
por: Chung, Ha‐Yeun, et al.
Publicado: (2022)

Utility of Plasma GDF-15 for Diagnosis and Prognosis Assessment of ICU-Acquired Weakness in Mechanically Ventilated Patients: Prospective Observational Study
por: Xie, Yongpeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pbopkrjpogrfkunm8dbpi2h38j